Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Tesamorelin in HIV Positive Patients
NCT02012556Phase 1Completed
- Sponsor
- Theratechnologies Inc.
- Start
- May 2008
- Primary completion
- Jul 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tesamorelin in HIV-associated lipodystrophy (HALS), sponsored by Theratechnologies Inc. Primary endpoints: Area under the Plasma Concentration versus Time Curve at Day 14, Peak Plasma Concentration at Day 14 and 5 more. Started May 2008; status: completed.
02
Drugs
tesamorelin
03
Conditions
HIV-associated lipodystrophy (HALS)
Beyond the preview
Go deeper on NCT02012556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02012556.